{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:44:09Z","timestamp":1789663449778,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T00:00:00Z","timestamp":1434412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81301827"],"award-info":[{"award-number":["81301827"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13048-015-0168-9","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T01:30:39Z","timestamp":1434591039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"8","author":[{"given":"Long","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Chiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,16]]},"reference":[{"issue":"1","key":"168_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/canjclin.53.1.5","volume":"53","author":"A Jemal","year":"2003","unstructured":"Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53(1):5\u201326.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"168_CR2","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/AOG.0b013e318264f794","volume":"120","author":"LA Baldwin","year":"2012","unstructured":"Baldwin LA, Huang B, Miller RW, Tucker T, Goodrich ST, Podzielinski I, et al. Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol. 2012;120(3):612\u20138.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"168_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1074\/mcp.R400006-MCP200","volume":"3","author":"IJ Jacobs","year":"2004","unstructured":"Jacobs IJ, Menon U. Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics. 2004;3(4):355\u201366.","journal-title":"Mol Cell Proteomics"},{"issue":"3","key":"168_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrc2583","volume":"9","author":"TA Yap","year":"2009","unstructured":"Yap TA, Carden CP, Kaye SB. Beyond chemotherapy: targeted therapies in ovarian cancer. Nat Rev Cancer. 2009;9(3):167\u201381.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"168_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ygyno.2003.08.004","volume":"91","author":"PL Judson","year":"2003","unstructured":"Judson PL, Geller MA, Bliss RL, Boente MP, Downs Jr LS, Argenta PA, et al. Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer. Gynecol Oncol. 2003;91(2):389\u201394.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"168_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ygyno.2007.07.073","volume":"107","author":"P Wimberger","year":"2007","unstructured":"Wimberger P, Heubner M, Otterbach F, Fehm T, Kimmig R, Kasimir-Bauer S. Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer. Gynecol Oncol. 2007;107(2):331\u20138.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"168_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mehy.2005.07.023","volume":"66","author":"Y Lu da","year":"2006","unstructured":"da Lu Y, Chen XL, Ding J. Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination - an effective strategy to improve clinical treatment. Med Hypotheses. 2006;66(1):45\u201351.","journal-title":"Med Hypotheses"},{"issue":"5","key":"168_CR8","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158(5):1110\u201322.","journal-title":"Cell"},{"issue":"1","key":"168_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.canlet.2013.12.019","volume":"346","author":"SH Lim","year":"2014","unstructured":"Lim SH, Becker TM, Chua W, Caixeiro NJ, Ng WL, Kienzle N, et al. Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer. Cancer Lett. 2014;346(1):24\u201333.","journal-title":"Cancer Lett"},{"issue":"2","key":"168_CR10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1183\/09031936.00002912","volume":"41","author":"AM Turner","year":"2013","unstructured":"Turner AM, McGowan L, Millen A, Rajesh P, Webster C, Langman G, et al. Circulating DBP level and prognosis in operated lung cancer: an exploration of pathophysiology. Eur Respir J. 2013;41(2):410\u20136.","journal-title":"Eur Respir J"},{"issue":"9\u201310","key":"168_CR11","first-page":"E715","volume":"8","author":"K Kolostova","year":"2014","unstructured":"Kolostova K, Cegan M, Bobek V. Circulating tumour cells in patients with urothelial tumours: enrichment and in vitro culture. Can Urol Assoc J. 2014;8(9\u201310):E715\u201320.","journal-title":"Can Urol Assoc J"},{"issue":"41","key":"168_CR12","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1038\/onc.2013.441","volume":"33","author":"C Driemel","year":"2014","unstructured":"Driemel C, Kremling H, Schumacher S, Will D, Wolters J, Lindenlauf N, et al. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer. Oncogene. 2014;33(41):4904\u201315.","journal-title":"Oncogene"},{"issue":"2","key":"168_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00280-014-2508-7","volume":"74","author":"KL Morris","year":"2014","unstructured":"Morris KL, Tugwood JD, Khoja L, Lancashire M, Sloane R, Burt D, et al. Circulating biomarkers in hepatocellular carcinoma. Cancer Chemother Pharmacol. 2014;74(2):323\u201332.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"168_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.acuro.2014.02.008","volume":"38","author":"V Medina-Villaamil","year":"2014","unstructured":"Medina-Villaamil V, Martinez-Breijo S, Portela-Pereira P, Quindos-Varela M, Santamarina-Cainzos I, Anton-Aparicio LM, et al. Circulating MicroRNAs in blood of patients with prostate cancer. Actas Urol Esp. 2014;38(10):633\u20139.","journal-title":"Actas Urol Esp"},{"issue":"7403","key":"168_CR15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10933","volume":"486","author":"SP Shah","year":"2012","unstructured":"Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 2012;486(7403):395\u20139.","journal-title":"Nature"},{"issue":"1","key":"168_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.28134","volume":"134","author":"K Tjensvoll","year":"2014","unstructured":"Tjensvoll K, Nordgard O, Smaaland R. Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications. Int J Cancer. 2014;134(1):1\u20138.","journal-title":"Int J Cancer"},{"issue":"1","key":"168_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/1354750X.2013.865275","volume":"19","author":"M Sang","year":"2014","unstructured":"Sang M, Wu X, Fan X, Zhou X, Zhou N. Multiple MAGE-A genes as surveillance marker for the detection of circulating tumor cells in patients with ovarian cancer. Biomarkers. 2014;19(1):34\u201342.","journal-title":"Biomarkers"},{"issue":"3","key":"168_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ygyno.2014.06.013","volume":"134","author":"ML Pearl","year":"2014","unstructured":"Pearl ML, Zhao Q, Yang J, Dong H, Tulley S, Zhang Q, et al. Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer. Gynecol Oncol. 2014;134(3):581\u201390.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"168_CR19","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1373\/clinchem.2014.224808","volume":"60","author":"JD Kuhlmann","year":"2014","unstructured":"Kuhlmann JD, Wimberger P, Bankfalvi A, Keller T, Scholer S, Aktas B, et al. ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance. Clin Chem. 2014;60(10):1282\u20139.","journal-title":"Clin Chem"},{"issue":"5","key":"168_CR20","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1525-1438.2007.00920.x","volume":"17","author":"C Schindlbeck","year":"2007","unstructured":"Schindlbeck C, Hantschmann P, Zerzer M, Jahns B, Rjosk D, Janni W, et al. Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIalpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow. Int J Gynecol Cancer. 2007;17(5):1047\u201355.","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"168_CR21","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1002\/ijc.25602","volume":"128","author":"P Wimberger","year":"2011","unstructured":"Wimberger P, Roth C, Pantel K, Kasimir-Bauer S, Kimmig R, Schwarzenbach H. Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients. Int J Cancer. 2011;128(11):2572\u201380.","journal-title":"Int J Cancer"},{"issue":"5","key":"168_CR22","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/IGC.0b013e3182907109","volume":"23","author":"T Fehm","year":"2013","unstructured":"Fehm T, Banys M, Rack B, Janni W, Marth C, Blassl C, et al. Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer. Int J Gynecol Cancer. 2013;23(5):839\u201345.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"168_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ygyno.2011.06.022","volume":"123","author":"K Behbakht","year":"2011","unstructured":"Behbakht K, Sill MW, Darcy KM, Rubin SC, Mannel RS, Waggoner S, et al. Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a gynecologic oncology group study. Gynecol Oncol. 2011;123(1):19\u201326.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"168_CR24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/cncr.10250","volume":"94","author":"C Marth","year":"2002","unstructured":"Marth C, Kisic J, Kaern J, Trope C, Fodstad O. Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis. Cancer. 2002;94(3):707\u201312.","journal-title":"Cancer"},{"issue":"1","key":"168_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ygyno.2008.09.021","volume":"112","author":"T Fan","year":"2009","unstructured":"Fan T, Zhao Q, Chen JJ, Chen WT, Pearl ML. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer. Gynecol Oncol. 2009;112(1):185\u201391.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"168_CR26","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/IGC.0b013e318216cb91","volume":"21","author":"B Aktas","year":"2011","unstructured":"Aktas B, Kasimir-Bauer S, Heubner M, Kimmig R, Wimberger P. Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy. Int J Gynecol Cancer. 2011;21(5):822\u201330.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"168_CR27","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ygyno.2014.03.016","volume":"133","author":"N Romero-Laorden","year":"2014","unstructured":"Romero-Laorden N, Olmos D, Fehm T, Garcia-Donas J, Diaz-Padilla I. Circulating and disseminated tumor cells in ovarian cancer: a systematic review. Gynecol Oncol. 2014;133(3):632\u20139.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"168_CR28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/IGC.0b013e31823de6ae","volume":"22","author":"S Polterauer","year":"2012","unstructured":"Polterauer S, Vergote I, Concin N, Braicu I, Chekerov R, Mahner S, et al. Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data. Int J Gynecol Cancer. 2012;22(3):380\u20135.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"168_CR29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S1470-2045(10)70292-8","volume":"12","author":"I Zapardiel","year":"2011","unstructured":"Zapardiel I, Morrow CP. New terminology for cytoreduction in advanced ovarian cancer. Lancet Oncol. 2011;12(3):214.","journal-title":"Lancet Oncol"},{"issue":"Suppl 7","key":"168_CR30","doi-asserted-by":"crossref","first-page":"vii218","DOI":"10.1093\/annonc\/mdq377","volume":"21","author":"JA Ledermann","year":"2010","unstructured":"Ledermann JA, Kristeleit RS. Optimal treatment for relapsing ovarian cancer. Ann Oncol. 2010;21 Suppl 7:vii218\u201322.","journal-title":"Ann Oncol"},{"issue":"9","key":"168_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"168_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.","journal-title":"Trials"},{"issue":"2","key":"168_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/jnci\/81.2.107","volume":"81","author":"CB Begg","year":"1989","unstructured":"Begg CB, Berlin JA. Publication bias and dissemination of clinical research. J Natl Cancer Inst. 1989;81(2):107\u201315.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"168_CR34","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ygyno.2011.05.028","volume":"122","author":"A Poveda","year":"2011","unstructured":"Poveda A, Kaye SB, McCormack R, Wang S, Parekh T, Ricci D, et al. Circulating tumor cells predict progression free survival and overall survival in patients with relapsed\/recurrent advanced ovarian cancer. Gynecol Oncol. 2011;122(3):567\u201372.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"168_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ygyno.2012.09.021","volume":"128","author":"E Obermayr","year":"2013","unstructured":"Obermayr E, Castillo-Tong DC, Pils D, Speiser P, Braicu I, Van Gorp T, et al. Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance \u2013 a study of the OVCAD consortium. Gynecol Oncol. 2013;128(1):15\u201321.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"168_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ygyno.2013.08.006","volume":"131","author":"JF Liu","year":"2013","unstructured":"Liu JF, Kindelberger D, Doyle C, Lowe A, Barry WT, Matulonis UA. Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients. Gynecol Oncol. 2013;131(2):352\u20136.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"168_CR37","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/IGC.0b013e3181a23c4c","volume":"19","author":"M Banys","year":"2009","unstructured":"Banys M, Solomayer EF, Becker S, Krawczyk N, Gardanis K, Staebler A, et al. Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies. Int J Gynecol Cancer. 2009;19(5):948\u201352.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"168_CR38","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ygyno.2006.05.049","volume":"103","author":"T Fehm","year":"2006","unstructured":"Fehm T, Becker S, Bachmann C, Beck V, Gebauer G, Banys M, et al. Detection of disseminated tumor cells in patients with gynecological cancers. Gynecol Oncol. 2006;103(3):942\u20137.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"168_CR39","first-page":"291","volume":"83","author":"P Magnowski","year":"2012","unstructured":"Magnowski P, Bochynski H, Nowak-Markwitz E, Zabel M, Spaczynski M. Circulating tumor cells (CTCs)--clinical significance in patients with ovarian cancer. Ginekol Pol. 2012;83(4):291\u20134.","journal-title":"Ginekol Pol"},{"issue":"224","key":"168_CR40","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra24.","journal-title":"Sci Transl Med"},{"issue":"3","key":"168_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00428-013-1509-y","volume":"464","author":"X Matias-Guiu","year":"2014","unstructured":"Matias-Guiu X, Davidson B. Prognostic biomarkers in endometrial and ovarian carcinoma. Virchows Arch. 2014;464(3):315\u201331.","journal-title":"Virchows Arch"},{"issue":"1","key":"168_CR42","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.suronc.2013.10.005","volume":"23","author":"A Pereira","year":"2014","unstructured":"Pereira A, Perez-Medina T, Magrina JF, Magtibay PM, Rodriguez-Tapia A, Perez-Milan F, et al. The impact of pelvic retroperitoneal invasion and distant nodal metastases in epithelial ovarian cancer. Surg Oncol. 2014;23(1):40\u20134.","journal-title":"Surg Oncol"},{"issue":"4","key":"168_CR43","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/ijc.28417","volume":"134","author":"T Fehm","year":"2014","unstructured":"Fehm T, Banys M, Rack B, Jager B, Hartkopf A, Taran FA, et al. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients. Int J Cancer. 2014;134(4):925\u201331.","journal-title":"Int J Cancer"},{"issue":"4","key":"168_CR44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127(4):679\u201395.","journal-title":"Cell"},{"issue":"5","key":"168_CR45","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/sj.bjc.6602418","volume":"92","author":"AE Ring","year":"2005","unstructured":"Ring AE, Zabaglo L, Ormerod MG, Smith IE, Dowsett M. Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer. 2005;92(5):906\u201312.","journal-title":"Br J Cancer"},{"issue":"136","key":"168_CR46","doi-asserted-by":"publisher","first-page":"136ra68","DOI":"10.1126\/scitranslmed.3003726","volume":"4","author":"T Forshew","year":"2012","unstructured":"Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DW, Kaper F, et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med. 2012;4(136):136ra68.","journal-title":"Sci Transl Med"},{"issue":"3","key":"168_CR47","doi-asserted-by":"publisher","first-page":"e0118631","DOI":"10.1371\/journal.pone.0118631","volume":"10","author":"S Ninomiya","year":"2015","unstructured":"Ninomiya S, Kawano M, Abe T, Ishikawa T, Takahashi M, Tamura M, et al. Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines. PLoS One. 2015;10(3):e0118631.","journal-title":"PLoS One"},{"issue":"1","key":"168_CR48","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1056\/NEJMc1306040","volume":"369","author":"L Weiss","year":"2013","unstructured":"Weiss L, Hufnagl C, Greil R. Circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 2013;369(1):93.","journal-title":"N Engl J Med"},{"issue":"9","key":"168_CR49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrc3820","volume":"14","author":"C Alix-Panabieres","year":"2014","unstructured":"Alix-Panabieres C, Pantel K. Challenges in circulating tumour cell research. Nat Rev Cancer. 2014;14(9):623\u201331.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"168_CR50","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1440-1827.2010.02584.x","volume":"60","author":"A Ali","year":"2010","unstructured":"Ali A, Furusato B, Ts\u2019o PO, Lum ZP, Elsamanoudi S, Mohamed A, et al. Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors. Pathol Int. 2010;60(10):667\u201372.","journal-title":"Pathol Int"},{"issue":"2","key":"168_CR51","first-page":"337","volume":"53","author":"S Wu","year":"2015","unstructured":"Wu S, Liu Z, Liu S, Lin L, Yang W, Xu J. Enrichment and enumeration of circulating tumor cells by efficient depletion of leukocyte fractions. Clin Chem Lab Med. 2015;53(2):337.","journal-title":"Clin Chem Lab Med"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-015-0168-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-015-0168-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-015-0168-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-015-0168-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T12:39:48Z","timestamp":1583152788000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-015-0168-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,16]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1186\/s13048-015-0168-9","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,16]]},"assertion":[{"value":"9 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"38"}}